ArticleTherapeutic advances in medical oncology2025

Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer.

Caner Kapar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.